首页> 外文期刊>Clinical and Experimental Gastroenterology >Incidence of catheter-related complications among Japanese patients with central venous catheters as well as patients with short bowel syndrome
【24h】

Incidence of catheter-related complications among Japanese patients with central venous catheters as well as patients with short bowel syndrome

机译:日本中央静脉导管患者和短肠综合征患者的导管相关并发症发生率

获取原文
       

摘要

Purpose: Short bowel syndrome (SBS) is a serious rare disorder that is usually managed with parenteral nutrition. Central venous catheter (CVC)-related complications are known to occur, but their incidence rates (IRs) in Japan are unknown. The aim of this study was to estimate the incidence of complications in Japanese patients with CVCs, including patients with SBS using CVCs. Patients and methods: A retrospective cohort study in 64,817 patients with CVCs, including 81 patients with SBS, between April 2008 and October 2016 using a claims database in Japan was conducted. IRs of complications were calculated as total events divided by total catheter-days among all patients with CVCs and among patients with SBS. Results: The majority (90%) of patients in the CVC and SBS cohorts were ≥18 years old. Overall, IRs of any type of complication were numerically higher in patients with SBS compared with all patients with CVCs (2.68 vs 1.95 cases per 1,000 catheter-days, respectively). Among patients with SBS, septicemia, infection, and inflammatory reaction were the only complications observed. The complications with the highest incidence were catheter-related bloodstream infections (CRBSIs) in both the overall CVC cohort and the SBS cohort with IRs of 1.35 and 2.68 cases per 1,000 catheter-days, respectively. The IR of any CVC-related complication was numerically higher in patients with SBS with cancer vs without cancer (3.44 vs 1.86 cases per 1,000 catheter-days, respectively). Conclusion: Our study quantifies the incidence of complications in patients with CVCs, including those with SBS, in Japan.
机译:目的:短肠综合征(SBS)是一种严重的罕见疾病,通常可以通过肠胃外营养来控制。已知发生与中央静脉导管(CVC)相关的并发症,但在日本其发生率(IR)未知。这项研究的目的是评估日本CVC患者,包括使用CVC的SBS患者的并发症发生率。患者和方法:使用日本的理赔数据库,在2008年4月至2016年10月之间对64,817例CVC患者(包括81例SBS患者)进行了回顾性队列研究。并发症的IR被计算为所有CVC患者和SBS患者的总事件数除以总导管天数。结果:CVC和SBS队列中的大多数(> 90%)患者≥18岁。总体而言,与所有CVC患者相比,SBS患者中任何类型的并发症的IR数值均更高(分别为每1,000个导管日2.68比1.95例)。在SBS患者中,仅观察到败血症,感染和炎症反应。总体CVC队列和SBS队列中发生率最高的并发症是导管相关的血流感染(CRBSI),每1000个导管日的IR分别为1.35和2.68例。患有癌症的SBS患者与未患有癌症的SBS患者的任何CVC相关并发症的IR均在数值上更高(分别为每1,000个导管日3.44比1.86例)。结论:我们的研究量化了日本CVC患者(包括SBS患者)并发症的发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号